Quarterly report pursuant to Section 13 or 15(d)

SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details)

v3.21.2
SELECTED FINANCIAL STATEMENT CAPTIONS - LIABILITIES (Details) - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Jun. 30, 2019
Accounts payable:      
Clinical and regulatory expenses $ 311 $ 232  
Professional fees 960 1,183  
Selling expenses 798 1,303  
Manufacturing costs 3,824 4,541  
Other vendors 128 18  
Total accounts payable 6,021 7,277  
Accrued interest payable, related parties 246 42  
Accrued interest payable 407 991  
Accrued expenses:      
Payroll expenses 998 891  
Government rebates and other rebates 1,943 1,355  
Due to EJ Holdings 406 238  
Other accrued expenses 356 704  
Total accrued expenses 3,703 3,188  
Total accounts payable and accrued expenses $ 10,377 $ 11,498 $ 11,517